Sai Life Sciences
Sai Life Sciences Share Price Chart
Sai Life Sciences last traded at ₹1,469.00 (2026-10-13). Over the past month the stock moved -7.9%, three months the stock moved +28.7%, year the stock moved +71.1%. Its closing range over 52 weeks is ₹795.00 – ₹1,671.80, with the latest close 12.1% below the high.
Closing prices up to 2026-10-13.
About Sai Life Sciences
Incorporated in 1999, Sai Life Sciences Ltd carries out contract research and manufacturing activities for customers engaged in pharmaceutical and bio technology industries[1]
Business Profile[1] Sai Life Sciences is an integrated CRDMO (Contract Research, Development and Manufacturing Organization) delivering end-to-end services across the pharmaceutical lifecycle from early drug discovery to commercial manufacturing.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Sai Life Sciences reported sales of ₹554.00 crore (+11.7%) and net profit of ₹73.00 crore (+21.7%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 554.00 | 148.00 | 27.00 | 73.00 | 3.45 |
| Mar 2026 | 602.00 | 177.00 | 29.00 | 104.00 | 4.92 |
| Dec 2025 | 556.00 | 188.00 | 34.00 | 100.00 | 4.75 |
| Sep 2025 | 537.00 | 146.00 | 27.00 | 84.00 | 4.00 |
| Jun 2025 | 496.00 | 121.00 | 24.00 | 60.00 | 2.90 |
| Mar 2025 | 580.00 | 158.00 | 27.00 | 88.00 | 4.24 |
| Dec 2024 | 440.00 | 120.00 | 27.00 | 54.00 | 2.59 |
| Sep 2024 | 396.00 | 102.00 | 26.00 | 42.00 | – |
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|
| Sales growth | +14.6% | +32.1% | +77.1% | +35.6% | +26.4% | +3.8% | +11.7% |
| Operating profit growth | +25.0% | +26.4% | +365.4% | +43.1% | +56.7% | +12.0% | +22.3% |
| Net profit growth | +35.0% | +57.1% | – | +100.0% | +85.2% | +18.2% | +21.7% |
| EPS growth | – | – | – | – | +83.4% | +16.0% | +19.0% |
| OPM % | 27.0% | 27.0% | 24.0% | 27.0% | 34.0% | 29.0% | 27.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Sai Life Sciences reported sales of ₹2,192.00 crore (+33.5%) and net profit of ₹349.00 crore (+101.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 2,192 | 631.00 | 29.00 | 349.00 | 16.48 |
| Mar 2025 | 1,642 | 390.00 | 24.00 | 173.00 | 8.32 |
| Mar 2024 | 1,419 | 288.00 | 20.00 | 95.00 | – |
| Mar 2023 | 1,157 | 167.00 | 14.00 | 24.00 | – |
| Mar 2022 | 841.00 | 125.00 | 15.00 | 16.00 | – |
| Mar 2021 | 751.00 | 164.00 | 22.00 | 65.00 | – |
| Mar 2020 | 725.00 | 170.00 | 23.00 | 80.00 | – |
| Mar 2019 | 695.00 | 175.00 | 25.00 | 73.00 | – |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales growth | +4.3% | +3.6% | +12.0% | +37.6% | +22.6% | +15.7% | +33.5% |
| Operating profit growth | -2.9% | -3.5% | -23.8% | +33.6% | +72.5% | +35.4% | +61.8% |
| Net profit growth | +9.6% | -18.8% | -75.4% | +50.0% | +295.8% | +82.1% | +101.7% |
| EPS growth | – | – | – | – | – | – | +98.1% |
| OPM % | 23.0% | 22.0% | 15.0% | 14.0% | 20.0% | 24.0% | 29.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Sai Life Sciences.
Get Free AI Stock Analysis FREE →Latest News
-
Sai Life Sciences Ltd. - moneycontrol.com
-
Sai Life Sciences Ltd. - Moneycontrol.com
-
Sai Life Sciences Ltd. - Moneycontrol.com
-
Sai Life Sciences to unveil new R&D facility in Sept 2026
Frequently Asked Questions
What is the share price of Sai Life Sciences today?
Sai Life Sciences shares were last quoted at ₹1,469.00 (-1.3% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Sai Life Sciences?
Sai Life Sciences has a price-to-earnings (P/E) ratio of 93.54 and a price-to-book (P/B) ratio of 13.24. The industry P/E is 53.33.
What is the 52-week high and low of Sai Life Sciences?
The 52-week high of Sai Life Sciences is ₹1,697.00 and the 52-week low is ₹786.15.
What is the market cap of Sai Life Sciences?
The market capitalisation of Sai Life Sciences is about ₹33,837.16 crore.
How did Sai Life Sciences perform in its latest quarterly results?
In the latest quarter (Jun 2026), Sai Life Sciences reported sales of ₹554.00 crore (+11.7%) and net profit of ₹73.00 crore (+21.7%), compared with the same quarter last year.
Is Sai Life Sciences a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Sai Life Sciences has a 3-year ROE of 13.00%, 3-year profit growth of 226.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Sai Life Sciences?
Promoters hold about 34.53% of Sai Life Sciences.
Which sector does Sai Life Sciences belong to?
Sai Life Sciences belongs to the Pharmaceuticals & Drugs sector.